These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6809893)

  • 1. Homologous and hybrid calcium complexes of A23187 and hypoglycemic sulfonylureas: nuclear magnetic resonance and conformational analysis.
    Deleers M; Brasseur R; Gelbcke M; Malaisse WJ
    J Inorg Biochem; 1982 Jun; 16(3):215-25. PubMed ID: 6809893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of hypoglycaemic sulphonylureas and antibiotic ionophores upon calcium translocation.
    Couturier E; Malaisse WJ
    Br J Pharmacol; 1980; 71(1):315-20. PubMed ID: 6781574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionophoretic activity of hypoglycemic sulfonylureas.
    Couturier E; Malaisse WJ
    Arch Int Pharmacodyn Ther; 1980 Jun; 245(2):323-34. PubMed ID: 6250506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isosteric metal complexes of ionophore A23187: a basis for cation selectivity.
    Pfeiffer DR; Deber CM
    FEBS Lett; 1979 Sep; 105(2):360-4. PubMed ID: 385347
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro.
    O'Brien RC; Luo M
    Metabolism; 1997 Dec; 46(12 Suppl 1):22-5. PubMed ID: 9439554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transport of Pr3+ by hypoglycemic sulfonylureas across liposomal membranes.
    Deleers M; Gelbcke M; Malaisse WJ
    FEBS Lett; 1983 Jan; 151(2):269-72. PubMed ID: 6403382
    [No Abstract]   [Full Text] [Related]  

  • 7. Solid-state properties and crystal structure of gliclazide.
    Winters CS; Shields L; Timmins P; York P
    J Pharm Sci; 1994 Mar; 83(3):300-4. PubMed ID: 8207672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression by 2-ketoisocaproate of the insulinotropic action of hypoglycemic sulfonylureas.
    Malaisse WJ; Mathias PC; Malaisse-Lagae F; Sener A
    Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):265-84. PubMed ID: 3922019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of gliquidone, glibenclamide, gliclazide and glipizide in middle-aged and aged subjects.
    Courtois P; Sener A; Herbaut C; Turc A; Malaisse WJ
    Res Commun Mol Pathol Pharmacol; 1999 Feb; 103(2):211-22. PubMed ID: 10461687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ionophore A23187. Solution conformations of the calcium complex and free acid deduced from proton and carbon-13 nuclear magnetic resonance studies.
    Deber CM; Pfieffer DR
    Biochemistry; 1976 Jan; 15(1):132-41. PubMed ID: 764856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality risk among sulfonylureas: a systematic review and network meta-analysis.
    Simpson SH; Lee J; Choi S; Vandermeer B; Abdelmoneim AS; Featherstone TR
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):43-51. PubMed ID: 25466239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure.
    Andersson C; Gislason GH; Jørgensen CH; Hansen PR; Vaag A; Sørensen R; Mérie C; Olesen JB; Weeke P; Schmiegelow M; Norgaard ML; Køber L; Torp-Pedersen C
    Diabetes Res Clin Pract; 2011 Oct; 94(1):119-25. PubMed ID: 21831467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gliclazide--a new antidiabetic agent--on blood platelet function in vitro and in vivo.
    Arfors KE; Bergqvist D; Tangen O
    Ups J Med Sci; 1980; 85(1):74-83. PubMed ID: 7385462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protonophoretic activity of hypoglycemic sulfonylureas in black lipid membranes.
    Deleers M; Brasseur R
    Pharmacol Res Commun; 1986 Feb; 18(2):129-36. PubMed ID: 3010341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
    Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T
    Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stoichiometry of calcium binding by hypoglycemic sulfonylureas.
    Deleers M; Brasseur R; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):181-201. PubMed ID: 6658185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposite effects of hypoglycemic and hyperglycemic sulfonamides upon ionophore-mediated calcium transport.
    Anjaneyulu R; Anjaneyulu K; Couturier E; Malaisse WJ
    Biochem Pharmacol; 1980 Jul; 29(13):1879-82. PubMed ID: 6772193
    [No Abstract]   [Full Text] [Related]  

  • 19. The structure of the calcium complex of A23187, a divalent cation ionophore antibiotic.
    Chaney MO; Jones ND; Debono M
    J Antibiot (Tokyo); 1976 Apr; 29(4):424-7. PubMed ID: 776918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of hypoglycemic sulfonylureas and negative phospholipids on calcium transport: ionic and conformational aspects.
    Deleers M; Grognet P; Mahy M; Brasseur R; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):407-24. PubMed ID: 6635329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.